US 9910031
Compositions and methods for modulating c-Rel-dependent cytokine production
granted A61PA61P1/02A61P1/04
Quick answer
US patent 9910031 (Compositions and methods for modulating c-Rel-dependent cytokine production) held by Madrigal Pharmaceuticals, Inc. expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P11/00